Targeting CDK1 in cancer: mechanisms and implications

Q Wang, AM Bode, T Zhang - NPJ precision oncology, 2023 - nature.com
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as
promising candidate targets for cancer treatment. These proteins complexed with cyclins …

The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia

JT Lee Jr, JA McCubrey - Leukemia, 2002 - nature.com
Abstract The Raf/MEK/ERK (MAPK) signal transduction cascade is a vital mediator of a
number of cellular fates including growth, proliferation and survival, among others. The focus …

Mechanisms underlying endothelial dysfunction in diabetes mellitus

U Hink, H Li, H Mollnau, M Oelze, E Matheis… - Circulation …, 2001 - Am Heart Assoc
Incubation of endothelial cells in vitro with high concentrations of glucose activates protein
kinase C (PKC) and increases nitric oxide synthase (NOS III) gene expression as well as …

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C

D Toullec, P Pianetti, H Coste, P Bellevergue… - Journal of Biological …, 1991 - Elsevier
Staurosporine is the most potent inhibitor of protein kinase C (PKC) described in the
literature with a half-maximal inhibitory concentration (IC50) of 10 nM. Nevertheless, this …

Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976

G Martiny-Baron, MG Kazanietz, H Mischak… - Journal of Biological …, 1993 - Elsevier
Indolocarbazoles have been identified as novel inhibitors of protein kinase C (PKC), with Gö
6976 as one of its most potent and selective representatives. Recombinant PKC isozymes …

[图书][B] Anticancer agents from natural products

GM Cragg, DGI Kingston, DJ Newman - 2005 - taylorfrancis.com
Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …

Rottlerin, a novel protein kinase inhibitor

M Gschwendt, HJ Muller, K Kielbassa, R Zang… - Biochemical and …, 1994 - Elsevier
Rottlerin, a compound from Mallotus philippinensis, is shown to inhibit protein kinases with
some specificity for PKC. To some extent, the novel inhibitor is able to differentiate between …

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

RM Stone, DJ DeAngelo, V Klimek, I Galinsky, E Estey… - Blood, 2005 - ashpublications.org
Leukemic cells from 30% of patients with acute myeloid leukemia (AML) have an activating
mutation in the FLT3 (fms-like tyrosine kinase) gene, which represents a target for drug …

Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro.

A Fasano, C Fiorentini, G Donelli… - The Journal of …, 1995 - Am Soc Clin Investig
The intracellular signaling involved in the mechanism of action of zonula occludens toxin
(ZOT) was studied using several in vitro and ex vivo models. ZOT showed a selective effect …

UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53

Q Wang, S Fan, A Eastman, PJ Worland… - JNCI: Journal of the …, 1996 - academic.oup.com
Background: Arrest of the cell cycle in G2 phase following DNA damage helps protect cell
viability by allowing time for DNA repair before entry into mitosis (M phase). Abrogation of …